Side effects across medicines
Medicines whose labels list dry skin
199 medicines have an FDA label that names dry skin in its boxed warning, warnings, adverse reactions, trial table, patient leaflet or Drug Facts “stop use” warning (of the labels PlainMeds reads: each medicine's quoted label and up to eight more, by route and wording). Among them, the most FAERS reports of dry skin name adapalene (45,426), omeprazole (2,870) and isotretinoin (2,425), through July 30, 2026. A label lists what its studies and reports found, and a report does not show that a medicine caused the event.
Check it at the source: the FDA FAERS public dashboard; FDA labels on DailyMed.
Which medicines' labels list dry skin?
Ordered by where the label names it, the boxed warning first, then by FAERS reports. The first 150 of the 199 are below; every other one is on its medicine record. A medicine whose own indications name it, because it treats it, is not counted.
| Medicine | Where a label names it | FAERS reports of dry skin |
|---|---|---|
| Palovarotene | warnings and precautions | none in the top 1,000 |
| Adapalene | adverse reactions | 45,426 |
| Omeprazole | adverse reactions | 2,870 |
| Isotretinoin | adverse reactions | 2,425 |
| Lenalidomide | adverse reactions | 2,336 |
| Palbociclib | adverse reactions | 1,432 |
| Cabozantinib | adverse reactions | 1,309 |
| Peginterferon alfa 2a | adverse reactions | 1,203 |
| Ribavirin | adverse reactions | 1,088 |
| Pregabalin | adverse reactions | 916 |
| Sunitinib | adverse reactions | 773 |
| Tacrolimus | adverse reactions (topical label) | 741 |
| Citalopram | adverse reactions | 674 |
| Ribociclib | adverse reactions | 663 |
| Panitumumab | adverse reactions | 656 |
| Celecoxib | adverse reactions | 550 |
| Sorafenib | adverse reactions | 509 |
| Cyclosporine | adverse reactions | 508 |
| Fulvestrant | adverse reactions | 494 |
| Bevacizumab | adverse reactions | 461 |
| Tiotropium | adverse reactions | 450 |
| Everolimus | adverse reactions | 439 |
| Cetuximab | adverse reactions | 425 |
| Fluorouracil | adverse reactions | 414 |
| Lamotrigine | adverse reactions | 412 |
| Lapatinib ditosylate | adverse reactions | 397 |
| Pomalidomide | adverse reactions | 371 |
| Oxaliplatin | adverse reactions | 331 |
| Nilotinib | adverse reactions | 319 |
| Mirtazapine | adverse reactions | 287 |
| Trametinib | adverse reactions | 280 |
| Olanzapine | adverse reactions | 262 |
| Mupirocin | adverse reactions | 240 |
| Pertuzumab | adverse reactions | 238 |
| Enzalutamide | adverse reactions | 236 |
| Axitinib | adverse reactions | 220 |
| Ripretinib | adverse reactions | 220 |
| Metronidazole | adverse reactions (topical label) | 218 |
| Afatinib | adverse reactions | 199 |
| Erlotinib | adverse reactions | 193 |
| Gefitinib | adverse reactions | 193 |
| Dabrafenib | adverse reactions | 191 |
| Natalizumab | adverse reactions | 179 |
| Leuprolide | adverse reactions | 178 |
| Imatinib | adverse reactions | 169 |
| Paroxetine | adverse reactions | 163 |
| Vemurafenib | adverse reactions | 155 |
| Oxybutynin | adverse reactions | 150 |
| Ponatinib | adverse reactions | 148 |
| Risperidone | adverse reactions | 145 |
| Pazopanib | adverse reactions | 141 |
| Varenicline | adverse reactions | 137 |
| Buspirone | adverse reactions | 136 |
| Alpelisib | adverse reactions | 129 |
| Acitretin | adverse reactions | 126 |
| Enfortumab vedotin | adverse reactions | 123 |
| Divalproex | adverse reactions | 116 |
| Thalidomide | adverse reactions | 103 |
| Brensocatib | adverse reactions | 96 |
| Testosterone | adverse reactions (transdermal label) | 96 |
| Calcium chloride, icodextrin, magnesium chloride, sodium chloride and sodium lactate | adverse reactions | 91 |
| Sirolimus | adverse reactions (topical label) | 82 |
| Goserelin | adverse reactions | 81 |
| Talquetamab | adverse reactions | 78 |
| Medroxyprogesterone | adverse reactions (intramuscular label) | 73 |
| Encorafenib | adverse reactions | 72 |
| Glatiramer | adverse reactions | 65 |
| Eszopiclone | adverse reactions | 64 |
| Glycopyrrolate | adverse reactions | 60 |
| Binimetinib | adverse reactions | 59 |
| Ammonium lactate | adverse reactions | 57 |
| Halobetasol | adverse reactions | 53 |
| Bicalutamide | adverse reactions | 52 |
| Neratinib | adverse reactions | 52 |
| Niacin | adverse reactions | 51 |
| Calcipotriene | adverse reactions | 49 |
| Voriconazole | adverse reactions | 46 |
| Glycopyrronium | adverse reactions | 43 |
| Tazarotene | adverse reactions | 42 |
| Vandetanib | adverse reactions | 41 |
| Temozolomide | adverse reactions | 39 |
| Selumetinib | adverse reactions | 38 |
| Avutometinib and defactinib | adverse reactions | 36 |
| Olodaterol and tiotropium | adverse reactions | 35 |
| Cobimetinib | adverse reactions | 34 |
| Amivantamab | adverse reactions | 32 |
| Azelaic acid | adverse reactions | 31 |
| Erdafitinib | adverse reactions | 31 |
| Acamprosate | adverse reactions | none in the top 1,000 |
| Adagrasib | adverse reactions | none in the top 1,000 |
| Amivantamab and hyaluronidase | adverse reactions | none in the top 1,000 |
| Amoxicillin and clarithromycin and lansoprazole | adverse reactions | none in the top 1,000 |
| Amoxicillin and omeprazole and rifabutin | adverse reactions | none in the top 1,000 |
| Amphotericin b | adverse reactions | none in the top 1,000 |
| Arformoterol | adverse reactions | none in the top 1,000 |
| Arsenic trioxide | adverse reactions | none in the top 1,000 |
| Asparaginase | adverse reactions | none in the top 1,000 |
| Atropine and pralidoxime | adverse reactions | none in the top 1,000 |
| Azacitidine | adverse reactions | none in the top 1,000 |
| Bedaquiline | adverse reactions | none in the top 1,000 |
| Bendamustine | adverse reactions | none in the top 1,000 |
| Benzoyl peroxide and clindamycin | adverse reactions | none in the top 1,000 |
| Bevacizumab-maly | adverse reactions | none in the top 1,000 |
| Bexarotene | adverse reactions | none in the top 1,000 |
| Brentuximab vedotin | adverse reactions | none in the top 1,000 |
| Brigatinib | adverse reactions | none in the top 1,000 |
| Caffeine | adverse reactions | none in the top 1,000 |
| Capivasertib | adverse reactions | none in the top 1,000 |
| Cefpodoxime | adverse reactions | none in the top 1,000 |
| Cevimeline | adverse reactions | none in the top 1,000 |
| Cidofovir | adverse reactions | none in the top 1,000 |
| Clindamycin and tretinoin | adverse reactions | none in the top 1,000 |
| Clomipramine | adverse reactions | none in the top 1,000 |
| Dacomitinib | adverse reactions | none in the top 1,000 |
| Daraxonrasib | adverse reactions | none in the top 1,000 |
| Darifenacin | adverse reactions | none in the top 1,000 |
| Dasatinib | adverse reactions | none in the top 1,000 |
| Datopotamab deruxtecan | adverse reactions | none in the top 1,000 |
| Decitabine | adverse reactions | none in the top 1,000 |
| Diclofenac and menthol and methyl salicylate | adverse reactions | none in the top 1,000 |
| Elranatamab | adverse reactions | none in the top 1,000 |
| Ensartinib | adverse reactions | none in the top 1,000 |
| Estazolam | adverse reactions | none in the top 1,000 |
| Etravirine | adverse reactions | none in the top 1,000 |
| Etuvetidigene autotemcel | adverse reactions | none in the top 1,000 |
| Floxuridine | adverse reactions | none in the top 1,000 |
| Fluoxetine and olanzapine | adverse reactions | none in the top 1,000 |
| Flurbiprofen | adverse reactions (oral label) | none in the top 1,000 |
| Fluvoxamine | adverse reactions | none in the top 1,000 |
| Ganciclovir | adverse reactions | none in the top 1,000 |
| Glycopyrrolate and neostigmine methylsulfate | adverse reactions | none in the top 1,000 |
| Hyaluronidase and pertuzumab and trastuzumab | adverse reactions | none in the top 1,000 |
| Inavolisib | adverse reactions | none in the top 1,000 |
| Lazertinib | adverse reactions | none in the top 1,000 |
| Levoketoconazole | adverse reactions | none in the top 1,000 |
| Levomilnacipran | adverse reactions | none in the top 1,000 |
| Lidocaine and tetracaine | adverse reactions | none in the top 1,000 |
| Lopinavir and ritonavir | adverse reactions | none in the top 1,000 |
| Lutetium lu 177 vipivotide tetraxetan | adverse reactions | none in the top 1,000 |
| Mexiletine | adverse reactions | none in the top 1,000 |
| Miconazole and petrolatum and zinc oxide | adverse reactions | none in the top 1,000 |
| Midodrine | adverse reactions | none in the top 1,000 |
| Midostaurin | adverse reactions | none in the top 1,000 |
| Mosunetuzumab | adverse reactions | none in the top 1,000 |
| Nefazodone | adverse reactions | none in the top 1,000 |
| Nilutamide | adverse reactions | none in the top 1,000 |
| Nisoldipine | adverse reactions | none in the top 1,000 |
| Nitisinone | adverse reactions | none in the top 1,000 |
| Pasireotide | adverse reactions (subcutaneous label) | none in the top 1,000 |
| Pegvaliase | adverse reactions | none in the top 1,000 |
Source: FDA drug labels via openFDA, read October 8, 2026; FAERS via openFDA, reports through July 30, 2026
Which of them have the most dry skin reports in FAERS?
Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; MedDRA preferred term “Dry Skin”
What next?
- Side effects across medicines
- every reaction on PlainMeds
- Report a side effect to the FDA
- MedWatch